ID: ALA537668

Max Phase: Preclinical

Molecular Formula: C28H50ClN3O6

Molecular Weight: 523.72

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CNC(=O)CCCNC(=O)[C@H](C)C[C@H](O)[C@@H](N)C[C@H](Cc1ccc(OC)c(OCCCOC)c1)C(C)C.Cl

Standard InChI:  InChI=1S/C28H49N3O6.ClH/c1-19(2)22(16-21-10-11-25(36-6)26(17-21)37-14-8-13-35-5)18-23(29)24(32)15-20(3)28(34)31-12-7-9-27(33)30-4;/h10-11,17,19-20,22-24,32H,7-9,12-16,18,29H2,1-6H3,(H,30,33)(H,31,34);1H/t20-,22+,23+,24+;/m1./s1

Standard InChI Key:  RVLFDKRINKJMPX-QFUPZHBKSA-N

Associated Targets(Human)

Renin 5251 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Callithrix jacchus 111 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Renin 103 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cathepsin D 510 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 523.72Molecular Weight (Monoisotopic): 523.3621AlogP: 2.67#Rotatable Bonds: 19
Polar Surface Area: 132.14Molecular Species: BASEHBA: 7HBD: 4
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.57CX LogP: 1.81CX LogD: -0.31
Aromatic Rings: 1Heavy Atoms: 37QED Weighted: 0.21Np Likeness Score: 0.05

References

1. Göschke R, Stutz S, Rasetti V, Cohen NC, Rahuel J, Rigollier P, Baum HP, Forgiarini P, Schnell CR, Wagner T, Gruetter MG, Fuhrer W, Schilling W, Cumin F, Wood JM, Maibaum J..  (2007)  Novel 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamide transition state peptidomimetics are potent and orally active inhibitors of human renin.,  50  (20): [PMID:17824679] [10.1021/jm070314y]

Source